HER2-EXPRESSING SOLID TUMORS
Clinical trials for HER2-EXPRESSING SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new HER2-EXPRESSING SOLID TUMORS trials appear
Sign up with your email to follow new studies for HER2-EXPRESSING SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene therapy takes aim at Hard-to-Treat HER2 cancers
Disease control Recruiting nowThis study tests a new gene therapy called VNX-202 for people with HER2-positive solid tumors. The therapy uses a harmless virus to deliver instructions that help the body's immune cells attack cancer. The trial has two parts: one for advanced cancers that have stopped responding…
Matched conditions: HER2-EXPRESSING SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Vironexis Biotherapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New mRNA drug takes on HER2 cancers in first human trial
Disease control Recruiting nowThis early-stage trial is testing a new mRNA-based drug called MT-304, alone or with the immunotherapy nivolumab, in adults with advanced HER2-expressing solid tumors. The main goals are to check safety, find the right dose, and get a first look at whether it shrinks tumors. Abou…
Matched conditions: HER2-EXPRESSING SOLID TUMORS
Phase: PHASE1 • Sponsor: Myeloid Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC